SCHEMBL5138129

SCHEMBL5138129

Cc1cc(Oc2ccccc2)nc2cc(-c3cn(C4CC(CN5CCC5)C4)c4ncncc34)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.46
INSR P06213 5/20 0.46
LCK P06239 4/20 0.46
KDR P35968 3/20 0.46
RET P07949 3/20 0.46
LYN P07948 2/20 0.46
KIT P10721 2/20 0.46
FGFR1 P11362 2/20 0.46
SRC P12931 2/20 0.46
FLT1 P17948 2/20 0.46
FLT4 P35916 2/20 0.46
FLT3 P36888 2/20 0.46
ERBB4 Q15303 2/20 0.46
PDPK1 O15530 2/20 0.46
KCNH2 Q12809 2/20 0.46
EGFR P00533 1/20 0.46
ERBB2 P04626 1/20 0.46
MET P08581 1/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL397648 0.87 IGF1R (0.63) IGF1RINSRLCKKDRRET
SCHEMBL5138853 0.80 IGF1R (0.43) IGF1RINSRLCKKDRRET
SCHEMBL399488 0.78 IGF1R (0.63) IGF1RINSRLCKKDRRET
SCHEMBL6633259 0.78 IGF1R (0.72) IGF1RINSRLCKKDRRET
SCHEMBL399489 0.78 IGF1R (0.61) IGF1RINSRLCKKDRRET
SCHEMBL5078959 0.78 LCK (0.36) IGF1RINSRLCKKDRRET
SCHEMBL5138284 0.77 IGF1R (0.43) IGF1RINSRLCKKDRRET
SCHEMBL400678 0.77 BTK (0.50) IGF1RINSRLCKKDRRET
SCHEMBL31652487 0.76 IGF1R (0.72) IGF1RINSRLCKKDRRET
SCHEMBL5317198 0.76 F2 (0.38) IGF1RINSRLCKKDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP claimed
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO claimed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO claimed